Step Therapy Rules: Insurance Requirements to Try Generics First

When your doctor prescribes a medication, you expect it to be covered by your insurance. But what if your insurer says you have to try cheaper drugs first-even if your doctor says they won’t work for you? That’s the reality of step therapy, a common insurance rule that forces patients to "fail" on lower-cost treatments before getting access to the one originally prescribed. It’s called a "fail-first" policy for a reason: you have to prove a cheaper option doesn’t work before the insurance will pay for the one your doctor believes is right.

How Step Therapy Actually Works

Step therapy isn’t random. It’s built into insurance formularies as a step-by-step ladder. At the bottom? Generic drugs. These are usually the first step. If you’re being treated for rheumatoid arthritis, for example, your insurer might require you to try methotrexate or an NSAID like ibuprofen before they’ll cover a biologic like Humira or Enbrel. If those don’t work-or cause side effects-you move up to the next step. Only then can you get the drug your doctor picked.

This isn’t just about savings. It’s a structured system. The Virginia Code defines it clearly: a step therapy protocol is a "sequence in which prescription drugs for a specified medical condition are covered." Insurers like Aetna and Blue Cross Blue Shield of Michigan lay out these steps in their member guides. One patient might need to try three different drugs over six months before approval comes through. And during that time, their condition can get worse.

Why Insurers Use Step Therapy

Insurance companies say they do this to keep costs down. Prescription drug spending has soared, and insurers are under pressure to control it. According to a 2021 Congressional Budget Office analysis, step therapy can cut pharmaceutical spending by 5% to 15% depending on the drug class. That’s billions of dollars saved across the system.

And it’s not just small plans. About 40% of all health plan drug coverage policies include step therapy requirements, according to NIH research. Most employer-sponsored plans use it. The practice has grown by 15% since 2018. For insurers, it’s a way to push patients toward the cheapest effective option-usually a generic. In fact, 90% of all prescriptions filled in the U.S. are for generics, which rarely require step therapy because they’re already low-cost.

But here’s the catch: what’s cheap for the insurer isn’t always best for the patient. A 2022 survey by the Arthritis Foundation found that 68% of patients experienced negative health outcomes because of step therapy. Forty-two percent reported disease progression during the required trials. One Reddit user, "ChronicPainWarrior," described waiting six months to get a biologic for rheumatoid arthritis. By the time approval came, joint damage had already worsened. That’s not hypothetical. It’s happening every day.

The Human Cost of Delayed Care

Step therapy doesn’t just delay treatment-it can cause irreversible harm. For conditions like multiple sclerosis, Crohn’s disease, or severe depression, waiting weeks or months for approval can mean losing mobility, function, or even quality of life. The American College of Rheumatology openly opposes step therapy because it puts patients at risk.

And the appeals process? It’s slow. Insurers often take four to eight weeks to review an exception request. Blue Cross Blue Shield of Michigan says their standard review takes 72 business hours-but that’s not always the case. Some patients wait a full month just to get a response. The American College of Rheumatology estimates doctors spend nearly 18 hours a week just filling out paperwork for prior authorizations and step therapy exceptions. That’s time they could be spending with patients.

Even worse: if you switch jobs or insurance plans, you often have to restart the entire step therapy process-even if you’ve been on the same medication for years. A patient who’s been stable on a biologic for three years might be forced to try three cheaper drugs again. That’s not medical logic. That’s bureaucracy.

When Exceptions Are Allowed

Thankfully, step therapy isn’t absolute. Federal and state laws require insurers to allow exceptions under certain conditions. The Safe Step Act, introduced multiple times since 2017, outlines five clear cases where insurers must bypass the step process:

• The required drug was tried before and didn’t work
• The required drug would cause severe or irreversible harm
• The required drug is contraindicated based on your medical history
• The required drug would prevent you from doing daily activities
• You’re already stable on your current medication and it was previously covered

These exceptions aren’t optional. If your doctor submits documentation showing one of these applies, the insurer must approve the request. But getting that documentation accepted? That’s another battle. Clinicians need to provide lab results, past treatment records, and sometimes even letters of medical necessity. It’s not a quick call. It’s a paper trail.

State vs. Federal Rules

Here’s where it gets messy. As of 2022, 29 states passed laws requiring insurers to offer step therapy exceptions. But here’s the catch: those laws only apply to fully-insured plans. That means if your employer pays for your insurance directly (a self-insured plan), state laws don’t touch it. And guess what? About 61% of Americans are covered by self-insured plans-regulated only by the federal Department of Labor.

That creates a huge loophole. You could live in a state with strong protections, but if your employer is self-insured, you get none of them. The Safe Step Act, reintroduced in 2021, aimed to fix this by extending the same protections to self-insured plans under ERISA. But it hasn’t passed yet. So right now, your access to timely care depends on where you live-and who your employer is.

What Patients Can Do

If you’re caught in step therapy:

1. Ask your doctor to file an exception request immediately. Don’t wait. Use the five criteria above as a checklist.
2. Get everything in writing. Emails, letters, prescriptions. Keep copies.
3. Call your insurer’s member services. Ask for a case manager. Some insurers assign one to complex cases.
4. Check if your drug manufacturer offers patient assistance. Nearly 80% of big pharma companies provide co-pay cards or free trials that can help you bypass step therapy temporarily.
5. If you’re denied, appeal. Most insurers have a formal appeals process. Don’t give up.

Some patients do find success. A 2023 GoodRx survey found 17% of people ended up managing their condition just fine on the generic drug they were required to try first. But that’s not the norm. For most, it’s a gamble with their health.

The Future of Step Therapy

Industry analysts predict step therapy will cover 55% of specialty drug prescriptions by 2025. That’s up from 40% today. More insurers are adding it. More states are trying to regulate it. But without federal action, the system will stay broken.

The goal isn’t to eliminate step therapy entirely. It can work when used fairly. But right now, it’s often used as a cost-cutting tool that ignores patient outcomes. Until insurers are required to respond to exceptions within days-not weeks-and until self-insured plans are held to the same rules as fully-insured ones, patients will keep paying the price-in pain, in time, and in health.